Use of new imaging techniques to predict tumour response to therapy (Q34096601)

31 July 2017

1 reference

title

Use of new imaging techniques to predict tumour response to therapy (English)

1 reference

31 July 2017

Vanessa N Harry

1

1 reference

31 July 2017

Scott I Semple

series ordinal

2

1 reference

31 July 2017

David E Parkin

series ordinal

3

1 reference

31 July 2017

Fiona J Gilbert

series ordinal

4

1 reference

31 July 2017

1 January 2010

1 reference

Lancet Oncology Commission

31 July 2017

1 reference

31 July 2017

11

1 reference

31 July 2017

1

1 reference

31 July 2017

92-102

1 reference

The cellular basis of tumor progression

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Functional MRI for anticancer therapy assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Early detection of response to radiation therapy in patients with brain malignancies using conventional and high b-value diffusion-weighted magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Diffusion changes in a tumor and peritumoral tissue after stereotactic irradiation for brain tumors: possible prediction of treatment response

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Diffusion MRI for prediction of response of rectal cancer to chemoradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

[Diffusion-weighted MRI--a new parameter for advanced rectal carcinoma?]

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Evaluation of tumour necrosis during chemotherapy with diffusion-weighted MR imaging: preliminary results in osteosarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Diffusion-weighted magnetic resonance imaging allows noninvasive in vivo monitoring of the effects of combretastatin a-4 phosphate after repeated administration

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

MRI-diffusion imaging of neuroblastomas: first results and correlation to histology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Dynamic contrast-enhanced magnetic resonance imaging in radiotherapeutic efficacy in the head and neck tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Assessment of Irradiated Brain Metastases by Means of Arterial Spin-Labeling and Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Contrast enhanced dynamic MRI of cervical carcinoma during radiotherapy: early prediction of tumour regression rate

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Tumor perfusion studies using fast magnetic resonance imaging technique in advanced cervical cancer: a new noninvasive predictive assay

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Post-radiotherapy contrast enhancement changes in fast dynamic MRI of cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Prediction of tumor control in patients with cervical cancer: analysis of combined volume and dynamic enhancement pattern by MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Prognostic value of dynamic MR imaging for non-small-cell lung cancer patients after chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Early detection of treatment response by diffusion-weighted 1H-NMR spectroscopy in a murine tumour in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer: Predicting Response with in Vivo1H MR Spectroscopy—A Pilot Study at 4 T

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Early in vivo detection of metabolic response: a pilot study of 1H MR spectroscopy in extracranial lymphoma and germ cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Predicting treatment response in non-Hodgkin's lymphoma from the pretreatment tumor content of phosphoethanolamine plus phosphocholine

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Fluorine-18 fluorodeoxyglucose positron emission tomographic maximal standardized uptake value predicts survival independent of clinical but not pathologic TNM staging of resected non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

FDG-PET prediction of head and neck squamous cell cancer outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Lymph node staging by positron emission tomography in patients with carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

[18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Monitoring primary breast cancer throughout chemotherapy using FDG-PET.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Baseline MRI delivery characteristics predict change in invasive ductal breast carcinoma PET metabolism as a result of primary chemotherapy administration.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

The relationship between vascular and metabolic characteristics of primary breast tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Where are we with imaging oxygenation in human tumours?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

Utility of FMISO PET in advanced head and neck cancer treated with chemoradiation incorporating a hypoxia-targeting chemotherapy agent

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970190-1

7 January 2021

10.1016/S1470-2045(09)70190-1

Identifiers

DOI

1 reference

31 July 2017

1 reference